Your browser doesn't support javascript.
loading
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity.
Hong, Tae Hee; Cha, Hongui; Shim, Joon Ho; Lee, Boram; Chung, Jongsuk; Lee, Chung; Kim, Nayoung K D; Choi, Yoon-La; Hwang, Soohyun; Lee, Yoomi; Park, Sehhoon; Jung, Hyun Ae; Kim, Ji-Yeon; Park, Yeon Hee; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil; Lee, Se-Hoon; Park, Woong-Yang.
Afiliação
  • Hong TH; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Cha H; Department of Digital Health, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.
  • Shim JH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee B; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Chung J; Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.
  • Lee C; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Kim NKD; Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.
  • Choi YL; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.
  • Hwang S; GENINUS Inc, Seoul, Korea.
  • Lee Y; GENINUS Inc, Seoul, Korea.
  • Park S; Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.
  • Jung HA; Department of Pathology and Translational Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim JY; Department of Pathology and Translational Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park WY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Immunother Cancer ; 8(2)2020 10.
Article em En | MEDLINE | ID: mdl-33077514
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carga Tumoral / Inibidores de Checkpoint Imunológico / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carga Tumoral / Inibidores de Checkpoint Imunológico / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article